LIVE: Refining the Cancer Cytogenetic Workup in Hematolymphoid Disease with Optical Genome Mapping

Horizons Webinar banner

LIVE WEBINAR: April 29, 2025 | 1:00pm-2:00pm ET

Registration includes the live webinar link (sent via zoom), the webinar recording, PDF of the slides, and continuing education credit (CME and CMLE).


Description:

Optical Genome Mapping (OGM) is emerging as a powerful genomic tool that offers high-resolution detection of structural variants, complementing or even surpassing traditional cytogenetic and molecular techniques. This session will focus on OGM’s application in hematolymphoid malignancies, where genomic profiling plays a critical role in risk stratification, treatment decisions, and prognostic evaluation. The lecture will provide an in-depth overview of OGM technology, its principles, and its advantages in clinical diagnostics.

Learning Objectives:
  • Explain the fundamentals of Optical Genome Mapping and how it compares to current genetic testing methodologies.
  • Discuss real-world clinical examples showcasing OGM potential in the cancer cytogenetic workup and integrating with clinical pathology findings.
  • Describe the challenges, limitations, and future directions of OGM in clinical practice.

picture of Wahab Khan, PhD

SPEAKER:
Wahab A. Khan, PhD

Dartmouth Health

Picture of Jeremiah Karrs, DO

SPEAKER:
Jeremiah X. Karrs, DO

Dartmouth Health

Picture of Sara Akhavanfard, MD, PhD, FACMG

MODERATOR:
Sara Akhavanfard, MD, PhD, FACMG

Case Western Reserve University 
University Hospitals Cleveland Medical Center

Duration: 1 Hour
Level of Instruction: Intermediate
Live webinar: April 29, 2025 | 1:00pm ET

How to Register:
  1. Click the "Register Now" Button
  2. Log in using your AMP credentials. If you do not have an AMP account, create a FREE account.

Continuing Education Credit Information

CME credit: 1.0
CMLE credit: 1.0 
Last day to claim credit: March 20, 2028

Accreditation Statements
AMA PRA Category 1 Credit(s)
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.


Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.